Treatment implications of the altered cytokine-insulin axis in neurodegenerative disease
The disappointments of a series of large anti-amyloid trials have brought home the point that until the driving force behind Alzheimer's disease, and the way it causes harm, are firmly established and accepted, researchers will remain ill-equipped to find
|Collections||ANU Research Publications|
|01_Clark_Treatment_implications_of_the_2013.pdf||881.5 kB||Adobe PDF||Request a copy|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.